4 II. Containment Effective

First Page		Document Content
Date: 2002-09-09 15:31:43 Science Laboratory equipment Biological hazard Security Recombinant DNA Nature Laboratory Pipette Asilomar Conference on Recombinant DNA Biology Biotechnology Safety		4 II. Containment Effective Add to Reading List Source URL: profiles.nlm.nih.gov Download Document from Source Website File Size: 1.004,57 KB Share Document on Facebook

	Biotechnology, BS "DBEFNJD.BQ 5IF"DBEFNJD.BQTFSWFTBTBTVHHFTUFEDPVSTFTFRVFODFPOMZ4UVEFOUTBSFOPUMJNJUFEUPUIJTQMBOJUJTNFBOUUPCFVTFEBT DocID: 1xTqy - View Document
	PDF Document DocID: 1wroO - View Document
	Building A Better Mousetrap: Patenting Biotechnology In The European Community DocID: 1vr7C - View Document
	BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prod DocID: 1vq6b - View Document
	Biotechnology Consultation Agency Response Letter BNF DocID: 1vpUZ - View Document